SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-041127
Filing Date
2007-02-27
Accepted
2007-02-27 16:56:03
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1444761
2 SEVERANCE AGREEMENT dex10162.htm EX-10.162 36784
3 SUBSIDIARIES OF THE REGISTRANT. dex21.htm EX-21 28341
4 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1985
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9562
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9550
7 SECTION 906 CFO CERTIFICATION dex321.htm EX-32.1 2665
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2789
  Complete submission text file 0001193125-07-041127.txt   1537859
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 07653930
SIC: 8731 Services-Commercial Physical & Biological Research